Ardian looks beyond Italy with Neopharmed reinvestment

Additional equity from joint investor NB Renaissance will help the company at a 'turning point' in its history, says Ardian director Giacomo Forti.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this